{"id":396901,"date":"2020-12-09T18:00:26","date_gmt":"2020-12-09T23:00:26","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=396901"},"modified":"2020-12-09T18:00:26","modified_gmt":"2020-12-09T23:00:26","slug":"deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","title":{"rendered":"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"},"content":{"rendered":"

<\/p>\n

DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm<\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reata Pharmaceuticals, Inc. (\u201cReata\u201d or \u201cthe Company\u201d) (NASDAQ: RETA<\/a>) for violations of the securities laws.\n<\/p>\n

\nThe investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Reata failed to produce MOXIe Part 2 study results sufficient to support marketing approval for omaveloxolone for the treatment of FA from the FDA without additional evidence. It was foreseeable that the FDA would not approve omaveloxolone for the treatment of FA based on the MOXIe Part 2 study alone. Based on these facts, the Company\u2019s public statements were false and materially misleading throughout the class period. When the market learned the truth about Reata, investors suffered damages.\n<\/p>\n

\nIf you are a shareholder who suffered a loss, click here to participate<\/a>.\n<\/p>\n

\nWe also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com<\/a>, or by email at brian@schallfirm.com<\/a>.\n<\/p>\n

\nThe Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.\n<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201209006035\/en\/<\/a><\/span><\/p>\n

\nThe Schall Law Firm
\n
Brian Schall, Esq.
\n
310-301-3335
\n
info@schallfirm.com
\n<\/a>
www.schallfirm.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reata Pharmaceuticals, Inc. (\u201cReata\u201d or \u201cthe Company\u201d) (NASDAQ: RETA) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Reata failed to produce MOXIe Part 2 study results sufficient to support marketing approval for omaveloxolone for the treatment of FA from the FDA without additional evidence. It was foreseeable that the FDA would not … <\/p>\n

Continue reading “DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-396901","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reata Pharmaceuticals, Inc. (\u201cReata\u201d or \u201cthe Company\u201d) (NASDAQ: RETA) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Reata failed to produce MOXIe Part 2 study results sufficient to support marketing approval for omaveloxolone for the treatment of FA from the FDA without additional evidence. It was foreseeable that the FDA would not … Continue reading "DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-09T23:00:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\",\"datePublished\":\"2020-12-09T23:00:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"},\"wordCount\":334,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\",\"name\":\"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-09T23:00:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","og_description":"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reata Pharmaceuticals, Inc. (\u201cReata\u201d or \u201cthe Company\u201d) (NASDAQ: RETA) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Reata failed to produce MOXIe Part 2 study results sufficient to support marketing approval for omaveloxolone for the treatment of FA from the FDA without additional evidence. It was foreseeable that the FDA would not … Continue reading \"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-09T23:00:26+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm","datePublished":"2020-12-09T23:00:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"},"wordCount":334,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","name":"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-09T23:00:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209006035r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-monday-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-reata-pharmaceuticals-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=396901"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396901\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=396901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=396901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=396901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}